Trial Profile
Effect of teneligliptin on endothelial dysfunction induced by postprandial hypelipidemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Metabolic syndrome
- Focus Pharmacodynamics
- 15 Jan 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 21 Dec 2013 New trial record